PreludeDx™ Presents Comparative Data at the Annual ASBrS Meeting Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT®

Results Show Black Women Had Significantly Higher Rates of Radiation Therapy Recommendation Compared to White Women with Similar Biosignature Scores LAGUNA HILLS, Calif., May 1, 2023 /PRNewswire/ — Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine…